Published Oct. 6, 2026. The Federal Trade Commission has warned 24 of the nation’s largest healthcare services companies that failing to provide patients with timely, accurate and complete price information may violate federal consumer-protection law.
The FTC announced the letters on Oct. 5. The agency focused on routine and non-emergency care scheduled in advance, when providers generally have an opportunity to disclose expected costs before a patient commits to treatment.
What the FTC told healthcare providers
The letters urge each recipient to review its pricing practices and correct problems quickly. The agency said price is a material term of a healthcare transaction and that omitting it may be deceptive when the omission is likely to mislead a reasonable consumer.
The FTC also warned that a disclosure may still be misleading when it excludes physician or facility fees, covers only part of a planned course of care, is inaccurate or arrives too late for a patient to compare alternatives.
CMS compliance is only a baseline
The agency said compliance with Centers for Medicare & Medicaid Services price-transparency rules does not create a safe harbor from the FTC Act. A provider may satisfy a CMS posting requirement yet still face scrutiny if its consumer-facing price information is incomplete, unclear or misleading.
The letters are warnings, not findings that every recipient violated the law. The FTC did not identify the 24 companies in its public announcement.
Why it matters for patients
Advance pricing can help patients compare facilities, understand likely out-of-pocket costs and ask whether a quoted estimate includes all major fees. Consumers should still confirm insurance-network status, deductibles and separate professional charges before scheduled care.
See more verified developments in Health News and practical coverage in Personal Finance.
Featured image: Photo by Nappy on Unsplash. Image is illustrative.